Author:
Pinggera Germar-Michael,Frauscher Ferdinand,Paduch Darius A.,Bolyakov Alex,Efros Mitchell,Kaminetsky Jed,Da Pozzo Luigi,Esler Anne,Cox David
Reference23 articles.
1. Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial;Porst;Eur Urol,2011
2. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study;Roehrborn;J Urol,2008
3. Tadalafil 2.5 or 5 mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: results of a randomized, placebo-controlled, double-blind study;Egerdie;J Sex Med,2012
4. Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial;Oelke;Eur Urol,2012
5. The mechanism of action of phophodiesterase type 5 inhibitors in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia;Giuliano;Eur Urol,2013
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献